It is well known that tumor cells are able to upregulate the expression of checkpoint molecules (such as CTLA-4, PD-L1, and PD-1), leading to anergy of cytotoxic T cells in the tumor microenvironment [133]. This evidence concerns the gene CTLA4 and neoplasm.